Adalimumab in patients with vision-threatening uveitis: real-world clinical experience
Saved in:
Main Authors: | Peter J McCluskey, Richard Symes, Sophia Zagora, Denis Wakefield, Nitin Verma, Timothy Lee Tang Lee Say, Verlyn Yang, Jacob M Fingret, Christine Younan, Elisa Eleanor Cornish, Anthony Sammel, Deborah Speden |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7c6dbb33da9f4c9288fae3d87d75ca5b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis
by: Kotaniemi K, et al.
Published: (2011) -
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator
by: Linda Cingolani, et al.
Published: (2021) -
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis
by: Hendrik Rusche, et al.
Published: (2021) -
Efficacy and safety of adalimumab in ankylosing spondylitis
by: Mounach A, et al.
Published: (2014) -
Adalimumab for the treatment of Crohn’s disease
by: Andrea Cassinotti, et al.
Published: (2008)